Call for Abstract
15th International Conference on Cell and Stem Cell Research, will be organized around the theme “The Novel Stem Cell Research and its Hype”
STEMCELL CONFERENCE 2022 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in STEMCELL CONFERENCE 2022
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Embryonic stem (ES) cells are cells derived from the early embryo that can be propagated indefinitely in the primitive undifferentiated state while remaining pluripotent; they share these properties with embryonic germ (EG) cells. Candidate Embryonic stem and embryonic germ cell lines from the human blastocyst and embryonic gonad can differentiate into multiple types of somatic cell.
- Track 1-1Molecular Alterations During Female Reproductive Aging
- Track 1-2Role of Sperm DNA Integrity In Fertility
- Track 1-3Fertilization And Infertility
- Track 1-4Embryo Implantation
- Track 1-5Role of Macrophages In The Placenta
- Track 1-6Factors of Human Implantation
- Track 1-7Stimulus Trigerred Acquisition of Pluripotency (STAP)
- Track 1-8Stimulus Trigerred Acquisition of Pluripotency (STAP)
- Track 2-1Stem Cells And Regeneration In Veterinary Science
- Track 2-2Cell Based Therapy In Veterinary Medicine
- Track 2-3Bio Science And Clinical Applications of Stem Cells In Veterinary Medicine
- Track 3-1Types of Gene Therapy
- Track 3-2Gene Therapy Techniques
- Track 3-3Gene Therapy Challenges
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition.The most well-established and widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers.
- Track 4-1Autoimmune Disease Stem Cell Treatment
- Track 4-2Blood And Skin Diseases
- Track 4-3Organ Cancer: Gastric cancer, Breast, Oral, Head And Neck Cancer
- Track 4-4Lymphoma
- Track 4-5Alzheimers And Stem Cells
- Track 4-6Periodontal Diseases and Stem Cells
- Track 5-1Bone Remodeling And Osteoporosis
- Track 5-2Single-cell Technology In Cancer Research
- Track 5-3Stem Cell Epigenetics And Disease
- Track 5-4Epigenetic regulation of stem cells differentiating
Self-reestablishment and multiplication of foundational microorganism populaces is controlled, to some degree, by affectation of apoptosis. The quantity of foundational microorganisms is thusly a harmony between those lost to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is accepted to be a dynamic procedure which changes because of natural conditions.
- Track 6-1Genomic Analysis And Molecular Basis of Cancer
- Track 6-2Cancer Stem Cells And Impaired Apoptosis
- Track 6-3Inflammatory Diseases And Cancer
- Track 6-4Epigenetics And Cancer Stem Cells
- Track 6-5Apoptosis And Haematopoietic Stem Cells
A stem-cell niche is an area of a tissue that provides a specific microenvironment, in which stem cells are present in an undifferentiated and self-renewable state. Cells of the stem-cell niche interact with the stem cells to maintain them or promote their differentiation. The general niche model involves the association between resident stem cells and heterologous cell types—the niche cells.
Stem Cell Banking is a facility that preserves stem cells derived from amniotic fluid for future use. Stem cell samples in private or family banks are preserved precisely for use by the individual person from whom such cells have been collected and the banking costs are paid by such person. The sample can later be retrieved only by that individual and for the use by such individual or, in many cases, by his or her first-degree blood relatives.
- Track 7-1Amniotic Stem Cell Bank
- Track 7-2Umbilical Cord Blood Banks
- Track 7-3Hematopoietic Stem Cell And Potential Non-Hematopoietic Stem Cells
- Track 7-4Invivo & Invitro Stem cell Microenvironment
- Track 7-5Cancer Stem Cell Niche
- Track 7-6Extracellular Matrix Mimicking strategies for Stem cell Niche
Cell and Gene Therapy is portrayed as a plan of techniques that modify the assertion of an individual's characteristics or fix unpredictable characteristics. Each system incorporates the association of a specific nucleic destructive. Nucleic acids are commonly not taken up by cells, in like manner extraordinary carriers; implied 'vectors' are required. Vectors can be of either famous or non-viral nature however Cell treatment is described as the association of living whole cells into the patient for the treatment of a contamination.
- Track 8-1Somatic Cell Nuclear Transfer (SCNT)
- Track 8-2Gene Therapy and Genetic Engineering
- Track 8-3Somatic Gene Therapy
- Track 8-4Germ Line Gene Therapy
- Track 8-5Cell Cancer Immunotherapy
Stem cell therapy is a type of cell therapy in which therapeutic efficacy exclusively attributed to the potency (function) of donor stem cells, presented in any quantity and purity. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
- Track 9-1Allogenic cell therapy
- Track 9-2Ubiquitination Pathways For Cancer Therapy
- Track 9-3Translational Studies For Cancer Stem Cell-Based Therapies
- Track 9-4Specific Cancer Immunotherapy
- Track 9-5Haematopoietic stem cell transplantation
- Track 9-6Messenchymal stem cell therapy
- Track 9-7Neural stem cell Therapy
- Track 9-8Human embryonic stem Cells
- Track 9-9Allogenic cell therapy
- Track 9-10Enantioselectivity And Chiral Complexing In Cancer Therapy
Cell signaling is part of any communication process that governs basic activities of cells and coordinates all cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated more effectively and, theoretically, artificial tissues may be created.
- Track 10-1Crosstalk
- Track 10-2Cell Signaling Dynamics
- Track 10-3Modern Approach in Cell Signaling
- Track 10-4Cell Adhesion and Cell Communication
- Track 10-5Immune Signaling
Stem cell transplantation, sometimes referred to as bone marrow transplant, is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplants commonly are used to treat Leukemia and lymphoma, cancers that affect the blood and lymphatic system.
- Track 11-1Allogeneic Bone marrow Transplantation
- Track 11-2Hematopoietic Stem Cell Transplantation
- Track 11-3Epithelial Transplantation
- Track 11-4Haploidentical Stem Cell Transplantation
- Track 11-5Transplantation In Primary Immunodeficiency
- Track 11-6Retinal Stem Cell Transplantation
- Track 11-7Myelodysplastic syndrome and drug therapy
- Track 11-8Challenges in Transplanting Stem Cells
Tissue engineering can be defined as the use of a combination of cells, engineering materials, and suitable biochemical factors to improve or replace biological functions in an effort to improve clinica l procedures for the repair of damaged tissues and organs.
- Track 12-1Trends & Applications In Tissue Engineering
- Track 12-2Scaffolds In Regenerative Medicine
- Track 12-3Tissue Repair And Regeneration
- Track 12-4Stem Cells Progress In In situ Revascularization And Grafting
- Track 12-5Regeneration Manufacturing Challenges for Regenerative Medicine
Stem cells: An undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent that are restricted to becoming a more limited population of cells.
- Track 13-1Embryonic stem cells
- Track 13-2Non-embryonic (adult) stem cells
- Track 13-3Induced pluripotent stem cells (iPSCs)
- Track 13-4Cord blood stem cells and amniotic fluid stem cells
- Track 13-5Tissue Stem Cells
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.
- Track 14-1Regenerative Approaches With Nanoparticles
- Track 14-2Decellularization
- Track 14-3Blastocyst Complementation
- Track 14-4Reprogramming And Creating Stem Cells
- Track 14-5Advanced Developments In Artificial Organ System
- Track 15-1Ethical Issues In Stem Cell Research
- Track 15-2Key Ethical Issues In Embryonic Stem Cell
- Track 15-3IPR
- Track 15-4Biosafety And RDNA Guidelines
- Track 15-5Governing Stem Cell Therapy And Fundings